z-logo
open-access-imgOpen Access
Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma
Author(s) -
Marlies Vanden Bempt,
Koen Debackere,
Sofie Demeyer,
Quentin Van Thillo,
Nienke Meeuws,
Cristina Prieto,
Sarah Provost,
Nicole Mentens,
Kris Jacobs,
Olga Gielen,
David Nittner,
Seishi Ogawa,
Keisuke Kataoka,
Carlos Graux,
Thomas Tousseyn,
Jan Cools,
Daan Dierickx
Publication year - 2022
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.2022016428
Subject(s) - ezh2 , cancer research , lymphoma , peripheral t cell lymphoma , biology , histone deacetylase , gene expression , t cell , histone , gene , immunology , immune system , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom